4:15 PM Ā· 15 August 2025

US Premarket: Wall Street on the rise šŸ“ˆUnitedHealth surges 10% driven by Berkshire Hathaway

US30
Indices
-
-
UnitedHealth
Stocks
UNH.US, UnitedHealth Group Inc
-
-

U.S. stock index futures traded slightly higher on Friday, though they pared some gains just ahead of the release of July retail sales data.

  • Among the indices, the Dow Jones Industrial Average (US30) stands out, supported by renewed buying interest in shares of key U.S. health insurer UnitedHealth (UNH.US). Berkshire Hathaway revealed a stake in the company, boosting its stock price. Similar gains are seen in homebuilding names Lennar and DR Horton.
  • Investors are also watching Intel, which is breaking above key technical resistance levels on news that the U.S. government may take a stake in the chipmaker.
  • U.S. President Donald Trump and Russian President Vladimir Putin are set to discuss a possible ceasefire in Ukraine (7 PM GMT)

Traders await key U.S. macroeconomic releases:

  • 12:30 PM GMT – July retail sales

  • 1:15 PM GMT – Industrial production

  • 2 PM GMT – University of Michigan consumer sentiment and inflation expectations (August prelim)

US30 (Daily Interval)

Source: xStation5

Company News

  • UnitedHealth (UNH.US) – Shares jumped 11% after Warren Buffett’s Berkshire Hathaway disclosed a new investment in the unpopular health insurer. Investors see this as a potential “value” opportunity despite regulatory uncertainty and possible penalties related to Medicare programs.

  • Intel (INTC.US) – Pre-market gains of nearly 4%, extending earlier advances, after Bloomberg reported the Trump administration is considering taking a stake in the chipmaker. The market views this move as strategically securing Intel’s position as a key domestic producer with reliable supply chains.

  • Applied Materials (AMAT.US) – Shares plunged nearly 15% after the semiconductor equipment maker issued weak fourth-quarter guidance due to sluggish Chinese demand. The report heightened concerns over tariff-related risks and underscored that heavy exposure to China is overshadowing growth in the U.S. business.

  • DR Horton (DHI.US) & Lennar (LEN.US) – Both up close to 4% after Berkshire Hathaway increased its exposure to the U.S. homebuilding sector, revealing a new stake in DR Horton and a significantly larger position in Lennar.

  • Target (TGT.US) – Shares fell nearly 2% after Bank of America downgraded the retailer from “neutral” to “underperform,” citing a “deteriorating” long-term outlook and mounting competitive pressure from major rivals.

  • SanDisk (SNDK.US) – Down nearly 10% despite strong quarterly results, as the flash memory maker failed to meet investors’ unofficial expectations, triggering profit-taking.

  • Tapestry (TPR.US) – Up 2% after Wells Fargo raised its price target while maintaining its “overweight” rating, saying the recent sell-off was overdone.

  • Twilio (TWLO.US) – Gained over 4% as the cloud communications company is set to join the S&P MidCap 400 following UnitedHealth’s acquisition of Amedisys, which could prompt increased institutional buying.

UnitedHealth in Focus

Following massive recent declines, UnitedHealth’s share price is now nearly 50% below its all-time high and still around 25–30% below its 200-day EMA (red line) — a situation last seen during the COVID-19 panic. Buffett’s involvement may signal to investors that UNH is now attractively valued, prompting Wall Street to reassess the company’s long-term fundamentals.

Intel Breakout

Intel shares moved above the 200-day EMA yesterday, reversing a downward trend. Today’s pre-market gains open the way toward local highs.

Source: xStation5

14 October 2025, 9:48 PM

Daily Summary: Powell pulls markets back up! šŸ“ˆ EURUSD higher

14 October 2025, 8:50 PM

EURUSD higher after Powell's speech! šŸ’¶šŸ“ˆ

14 October 2025, 8:19 PM

Salesforce announces partnerships with OpenAI and Anthropic🚨

14 October 2025, 7:25 PM

Intel down 5% šŸ“‰

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.